Pliant Therapeutics (PLRX) Shares Issued (2019 - 2023)

Pliant Therapeutics (PLRX) has 5 years of Shares Issued data on file, last reported at $270.3 million in Q1 2023.

• Shares Issued for Q1 2023 came in at $270.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $270.3 million (up 25.0% YoY), and the FY2023 annual result was $270.3 million, up 25.0% from the prior year.
• Shares Issued rose to $270.3 million in Q1 2023 per PLRX's latest filing, from $216.2 million in the prior quarter.
• Over five years, Shares Issued peaked at $270.3 million in Q1 2023 and troughed at -$143.1 million in Q3 2020.
• A 5-year average of $28.6 million and a median of $198500.0 in 2020 frame the typical range for Shares Issued.
• The sharpest annual moves came in 2020 and 2022: Shares Issued slumped 1022378.57% in 2020, then soared 30697.86% in 2022.
• A 5-year view of Shares Issued shows it stood at -$146000.0 in 2019, then tumbled by 6446.58% to -$9.6 million in 2020, then jumped by 74.44% to -$2.4 million in 2021, then soared by 8949.82% to $216.2 million in 2022, then gained by 25.0% to $270.3 million in 2023.
• Business Quant data shows PLRX's Shares Issued at $270.3 million in Q1 2023, $216.2 million in Q3 2022, and -$2.4 million in Q4 2021.